Take home message?Enrique and Apop and all the other gurus here. I want to make sure I'm getting the "take home message" right. What makes us shine when compared to CG Oncology is the simple fact that we are achieving very close to the same results with only 1-2 treatments right? They require many more treatments to arrive at the CR numbers they have achieved if I'm understanding this correctly. Furthermore, we have yet to see their longer term efficacy results and we are at least able to look out to 450 days with some of our patients. Again with only 1-2 treatments. So who knows what numbers we might see with multiple treatments in the future. Having said these things we should be very attractive to a partner out there should we also receive a patent for an immunicological intravenous approach I would hope as a combined treatment. Just thinking out loud to see how you folks see us stacking up against the closest competitor. Thank you for any insight and clarification and comments!